問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Linkou Chang Gung Medical Foundation
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
下載
2016-01-01 - 2017-06-30
Condition/Disease
Test Drug
Participate Sites1Sites
Study ended1Sites
2015-08-01 - 2016-07-31
Terminated1Sites
Division of Nuclear Medicine
2015-10-01 - 2017-09-30
2015-08-01 - 2018-07-31
Division of Neurology
2014-08-01 - 2019-07-31
2017-01-01 - 2019-12-31
Prostate Adenocarcinoma
[11C]Choline ([11C]Methyl-dimethyl-2-hydroxyethyl-ammonium), Glass vial with 40-331mCi of 11C choline in aqueous 0.9% sodium
Recruiting1Sites
2016-07-01 - 2023-05-09
2017-08-01 - 2020-07-31
2017-08-01 - 2021-12-31
2017-08-01 - 2023-12-01
全部
